| Net income (loss) | |
| Depreciation and amortization | |
| Gain on assets reclassified from held for sale status | |
| Equity-based compensation | 20.17M |
| Provisions for inventory obsolescence | |
| Tax effect of stock options and awards exercised | |
| Excess tax benefit received on exercise of equity-based awards | -1.74M |
| (Loss) gain on sale of property and equipment | 50K |
| Other-than-temporary impairment losses | |
| Deferred income taxes | 2.46M |
| Trade receivables | -18.94M |
| Inventories | -2.94M |
| Prepaid expenses and other current assets | |
| Trade payables and accrued liabilities | 3.21M |
| Income taxes | 4.49M |
| Other, net | 5.39M |
| Net cash provided by operating activities | |
| Proceeds from sales or maturities of short-term investments | |
| Proceeds from sales or issuer calls of long-term investments | |
| Purchases of long-term investments | |
| Purchases of short-term investments | |
| Cash paid for acquired businesses, net of acquired cash | 0 |
| Proceeds from sales of property, plant and equipment | |
| Purchases of property, plant and equipment | -6.5M |
| Net cash used in investing activities | |
| Proceeds from exercise of equity-based awards | |
| Excess tax benefit received on exercise of equity-based awards | |
| Proceeds of long-term debt | |
| Repayments of long-term debt | |
| Debt issuance costs | |
| Credit facility commitment fee | |
| Dividends paid | -51.2M |
| Net cash (used in) provided by financing activities | |
| Effect of exchange rates on cash and cash equivalents | 1.16M |
| Net increase (decrease) in cash and cash equivalents | 36.64M |
| Cash and cash equivalents as of the beginning of the period | 247.4M |
| Cash and cash equivalents as of the end of the period | 284.05M |